(Q44990348)

English

Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity (English)
Volker Heinemann
T R Jeffrey Evans
Roland Andersson

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit